Henan Taloph Pharmaceutical Stock Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.014x

Henan Taloph Pharmaceutical Stock Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Henan Taloph Pharmaceutical Stock Co Ltd (600222) has a cash flow conversion efficiency ratio of 0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥22.69 Million ≈ $3.32 Million USD) by net assets (CN¥1.65 Billion ≈ $241.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Henan Taloph Pharmaceutical Stock Co Ltd (1998–2025)

Cash flow conversion efficiency of Henan Taloph Pharmaceutical Stock Co Ltd from 1998 to 2025. This chart illustrates how Henan Taloph Pharmaceutical Stock Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Henan Taloph Pharmaceutical Stock Co Ltd stock quote for real-time trading data and today's change.

Henan Taloph Pharmaceutical Stock Co Ltd Cash Flow Conversion Ratio Explained

Henan Taloph Pharmaceutical Stock Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Henan Taloph Pharmaceutical Stock Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Henan Taloph Pharmaceutical Stock Co Ltd ranked by their cash flow conversion efficiency. Also see 600222 company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Fujian Yongfu Power Engineering Co Ltd Class A SHE:300712	0.100x
LG Chem Ltd KO:051915	0.053x
Changzhou Almaden Co Ltd SHE:002623	-0.017x
Visco Vision Inc. TW:6782	0.061x
SAPPI LTD ADR/1 RC 1 F:SPIA	0.023x
ShaoYang Victor Hydraulics Co.Ltd SHE:301079	N/A
Zhangjiagang Guangda Special Material Co Ltd SHG:688186	-0.017x
Universal Health Realty Income Trust NYSE:UHT	0.086x

Annual Cash Flow Conversion Efficiency for Henan Taloph Pharmaceutical Stock Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Henan Taloph Pharmaceutical Stock Co Ltd from 1998 to 2025. Review 600222 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.66 Billion ≈ $243.28 Million	CN¥47.16 Million ≈ $6.90 Million	0.028x	+216.53%
2024-12-31	CN¥1.63 Billion ≈ $237.97 Million	CN¥-39.59 Million ≈ $-5.79 Million	-0.024x	-190.35%
2023-12-31	CN¥1.62 Billion ≈ $237.55 Million	CN¥43.74 Million ≈ $6.40 Million	0.027x	+134.96%
2022-12-31	CN¥1.61 Billion ≈ $236.19 Million	CN¥-124.41 Million ≈ $-18.20 Million	-0.077x	-237.49%
2021-12-31	CN¥1.78 Billion ≈ $260.12 Million	CN¥99.66 Million ≈ $14.58 Million	0.056x	+16.86%
2020-12-31	CN¥1.53 Billion ≈ $223.97 Million	CN¥73.43 Million ≈ $10.74 Million	0.048x	+51.55%
2019-12-31	CN¥1.31 Billion ≈ $191.96 Million	CN¥41.53 Million ≈ $6.08 Million	0.032x	-63.14%
2018-12-31	CN¥1.39 Billion ≈ $203.58 Million	CN¥119.47 Million ≈ $17.48 Million	0.086x	+459.02%
2017-12-31	CN¥1.51 Billion ≈ $220.70 Million	CN¥23.17 Million ≈ $3.39 Million	0.015x	-67.36%
2016-12-31	CN¥1.50 Billion ≈ $219.49 Million	CN¥70.60 Million ≈ $10.33 Million	0.047x	+43.24%
2015-12-31	CN¥1.50 Billion ≈ $219.41 Million	CN¥49.27 Million ≈ $7.21 Million	0.033x	-56.47%
2014-12-31	CN¥1.19 Billion ≈ $173.57 Million	CN¥89.54 Million ≈ $13.10 Million	0.075x	+1340.44%
2013-12-31	CN¥1.09 Billion ≈ $159.85 Million	CN¥-6.65 Million ≈ $-972.81K	-0.006x	-104.57%
2012-12-31	CN¥656.50 Million ≈ $96.07 Million	CN¥87.45 Million ≈ $12.80 Million	0.133x	+79526.32%
2011-12-31	CN¥628.89 Million ≈ $92.03 Million	CN¥105.20K ≈ $15.39K	0.000x	+100.51%
2010-12-31	CN¥609.32 Million ≈ $89.16 Million	CN¥-20.00 Million ≈ $-2.93 Million	-0.033x	-189.72%
2009-12-31	CN¥586.04 Million ≈ $85.76 Million	CN¥21.45 Million ≈ $3.14 Million	0.037x	+12.00%
2008-12-31	CN¥554.97 Million ≈ $81.21 Million	CN¥18.13 Million ≈ $2.65 Million	0.033x	-20.12%
2007-12-31	CN¥521.57 Million ≈ $76.32 Million	CN¥21.34 Million ≈ $3.12 Million	0.041x	+1149.87%
2006-12-31	CN¥487.05 Million ≈ $71.27 Million	CN¥1.59 Million ≈ $233.25K	0.003x	+459.04%
2005-12-31	CN¥471.96 Million ≈ $69.06 Million	CN¥276.30K ≈ $40.43K	0.001x	-98.54%
2004-12-31	CN¥455.68 Million ≈ $66.68 Million	CN¥18.25 Million ≈ $2.67 Million	0.040x	+371.94%
2003-12-31	CN¥440.61 Million ≈ $64.48 Million	CN¥3.74 Million ≈ $547.22K	0.008x	-51.32%
2002-12-31	CN¥428.30 Million ≈ $62.67 Million	CN¥7.47 Million ≈ $1.09 Million	0.017x	-86.79%
2001-12-31	CN¥416.84 Million ≈ $61.00 Million	CN¥55.03 Million ≈ $8.05 Million	0.132x	+6089.51%
2000-12-31	CN¥410.41 Million ≈ $60.06 Million	CN¥875.36K ≈ $128.09K	0.002x	-99.14%
1999-12-31	CN¥401.57 Million ≈ $58.76 Million	CN¥99.32 Million ≈ $14.53 Million	0.247x	+36.58%
1998-12-31	CN¥154.84 Million ≈ $22.66 Million	CN¥28.04 Million ≈ $4.10 Million	0.181x	--

About Henan Taloph Pharmaceutical Stock Co Ltd

SHG:600222 China Drug Manufacturers - Specialty & Generic

Market Cap

$544.17 Million

CN¥3.72 Billion CNY

Market Cap Rank

#11442 Global

#3214 in China

Share Price

CN¥6.48

Change (1 day)

-3.14%

52-Week Range

CN¥6.35 - CN¥8.95

All Time High

CN¥10.35